Sreekala Nair

Title: Sreekala Nair: Innovator in Therapeutic Compounds

Introduction

Sreekala Nair, based in Bengaluru, India, is an accomplished inventor known for her contributions to therapeutic compounds. With a strong focus on addressing diseases linked to cellular growth, her innovative work embodies the essence of modern medicine.

Latest Patents

Nair holds a patent for "Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors." This noteworthy invention presents novel compounds, represented by general Formula (I), along with their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs. These compounds have dual capabilities, inhibiting both LSD and HDAC, which positions them as potential therapeutic agents for conditions such as malignant tumors, schizophrenia, Alzheimer's disease, Parkinson's disease, and similar ailments.

Career Highlights

Sreekala Nair is currently associated with Jubilant Epicore LLC, where her research continues to push the boundaries of scientific discovery in therapeutic applications. Her expertise and innovative spirit have made significant impacts in her field.

Collaborations

Throughout her career, Nair has collaborated with esteemed colleagues, including Sridharan Rajagopal and Mahanandeesha S Hallur. These partnerships illustrate her dedication to working within teams to achieve common goals in innovation and development.

Conclusion

Sreekala Nair represents a vibrant example of an inventor driving change in healthcare through her innovative research in therapeutic compounds. Her patent showcases the untapped potential within her field, aiming to tackle some of the most pressing health challenges of our time. As she continues her work at Jubilant Epicore LLC, the future looks promising for advancements inspired by her contributions.